▶ 調査レポート

世界の計算免疫学市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Computational Immunology Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の計算免疫学市場規模・現状・予測(2021年-2027年) / Global Computational Immunology Market Size, Status and Forecast 2021-2027 / QYR2104Z1518資料のイメージです。• レポートコード:QYR2104Z1518
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、125ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、計算免疫学のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(がん診断・治療、逆ワクチン、免疫系モデリング)、用途別市場規模(アレルギー予測データベース、分析リソースデータベース、国際免疫遺伝学システム、免疫エピトープオントロジー、免疫エピトープデータベース)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・計算免疫学の市場動向
・企業の競争状況、市場シェア
・計算免疫学の種類別市場規模(がん診断・治療、逆ワクチン、免疫系モデリング)
・計算免疫学の用途別市場規模(アレルギー予測データベース、分析リソースデータベース、国際免疫遺伝学システム、免疫エピトープオントロジー、免疫エピトープデータベース)
・計算免疫学の北米市場規模2016-2027(アメリカ、カナダ)
・計算免疫学のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・計算免疫学のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・計算免疫学の中南米市場規模2016-2027(メキシコ、ブラジル)
・計算免疫学の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(EpiVax、Novozymes Biopharma、ioGenetics、International Society of Vaccines、IMGT、Dassault Systemes、Certara、Chemical Computing Group、Compugen、Genedata AG、Insilico Biotechnology AG、Leadscope Inc、Nimbus Discovery、Strand Life Sciences、Schrodinger、Simulation Plus、Rosa & Co)
・結論

Computational Immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field’s main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.

Market Analysis and Insights: Global Computational Immunology Market
The global Computational Immunology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Computational Immunology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Computational Immunology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Computational Immunology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Computational Immunology market.

Global Computational Immunology Scope and Market Size
Computational Immunology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Computational Immunology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling

Segment by Application
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology Of Immune Epitopes
Immune Epitope Database

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
International Society of Vaccines
IMGT
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Immunology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer Diagnosis & Therapy
1.2.3 Reverse Vaccinology
1.2.4 Immune System Modeling
1.3 Market by Application
1.3.1 Global Computational Immunology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology Of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Computational Immunology Market Perspective (2016-2027)
2.2 Computational Immunology Growth Trends by Regions
2.2.1 Computational Immunology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Computational Immunology Historic Market Share by Regions (2016-2021)
2.2.3 Computational Immunology Forecasted Market Size by Regions (2022-2027)
2.3 Computational Immunology Industry Dynamic
2.3.1 Computational Immunology Market Trends
2.3.2 Computational Immunology Market Drivers
2.3.3 Computational Immunology Market Challenges
2.3.4 Computational Immunology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Computational Immunology Players by Revenue
3.1.1 Global Top Computational Immunology Players by Revenue (2016-2021)
3.1.2 Global Computational Immunology Revenue Market Share by Players (2016-2021)
3.2 Global Computational Immunology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Computational Immunology Revenue
3.4 Global Computational Immunology Market Concentration Ratio
3.4.1 Global Computational Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Immunology Revenue in 2020
3.5 Computational Immunology Key Players Head office and Area Served
3.6 Key Players Computational Immunology Product Solution and Service
3.7 Date of Enter into Computational Immunology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Immunology Breakdown Data by Type
4.1 Global Computational Immunology Historic Market Size by Type (2016-2021)
4.2 Global Computational Immunology Forecasted Market Size by Type (2022-2027)

5 Computational Immunology Breakdown Data by Application
5.1 Global Computational Immunology Historic Market Size by Application (2016-2021)
5.2 Global Computational Immunology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Computational Immunology Market Size (2016-2027)
6.2 North America Computational Immunology Market Size by Type
6.2.1 North America Computational Immunology Market Size by Type (2016-2021)
6.2.2 North America Computational Immunology Market Size by Type (2022-2027)
6.2.3 North America Computational Immunology Market Size by Type (2016-2027)
6.3 North America Computational Immunology Market Size by Application
6.3.1 North America Computational Immunology Market Size by Application (2016-2021)
6.3.2 North America Computational Immunology Market Size by Application (2022-2027)
6.3.3 North America Computational Immunology Market Size by Application (2016-2027)
6.4 North America Computational Immunology Market Size by Country
6.4.1 North America Computational Immunology Market Size by Country (2016-2021)
6.4.2 North America Computational Immunology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Computational Immunology Market Size (2016-2027)
7.2 Europe Computational Immunology Market Size by Type
7.2.1 Europe Computational Immunology Market Size by Type (2016-2021)
7.2.2 Europe Computational Immunology Market Size by Type (2022-2027)
7.2.3 Europe Computational Immunology Market Size by Type (2016-2027)
7.3 Europe Computational Immunology Market Size by Application
7.3.1 Europe Computational Immunology Market Size by Application (2016-2021)
7.3.2 Europe Computational Immunology Market Size by Application (2022-2027)
7.3.3 Europe Computational Immunology Market Size by Application (2016-2027)
7.4 Europe Computational Immunology Market Size by Country
7.4.1 Europe Computational Immunology Market Size by Country (2016-2021)
7.4.2 Europe Computational Immunology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Computational Immunology Market Size (2016-2027)
8.2 Asia-Pacific Computational Immunology Market Size by Type
8.2.1 Asia-Pacific Computational Immunology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Computational Immunology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Computational Immunology Market Size by Type (2016-2027)
8.3 Asia-Pacific Computational Immunology Market Size by Application
8.3.1 Asia-Pacific Computational Immunology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Computational Immunology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Computational Immunology Market Size by Application (2016-2027)
8.4 Asia-Pacific Computational Immunology Market Size by Region
8.4.1 Asia-Pacific Computational Immunology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Computational Immunology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Computational Immunology Market Size (2016-2027)
9.2 Latin America Computational Immunology Market Size by Type
9.2.1 Latin America Computational Immunology Market Size by Type (2016-2021)
9.2.2 Latin America Computational Immunology Market Size by Type (2022-2027)
9.2.3 Latin America Computational Immunology Market Size by Type (2016-2027)
9.3 Latin America Computational Immunology Market Size by Application
9.3.1 Latin America Computational Immunology Market Size by Application (2016-2021)
9.3.2 Latin America Computational Immunology Market Size by Application (2022-2027)
9.3.3 Latin America Computational Immunology Market Size by Application (2016-2027)
9.4 Latin America Computational Immunology Market Size by Country
9.4.1 Latin America Computational Immunology Market Size by Country (2016-2021)
9.4.2 Latin America Computational Immunology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Computational Immunology Market Size (2016-2027)
10.2 Middle East & Africa Computational Immunology Market Size by Type
10.2.1 Middle East & Africa Computational Immunology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Computational Immunology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Computational Immunology Market Size by Type (2016-2027)
10.3 Middle East & Africa Computational Immunology Market Size by Application
10.3.1 Middle East & Africa Computational Immunology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Computational Immunology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Computational Immunology Market Size by Application (2016-2027)
10.4 Middle East & Africa Computational Immunology Market Size by Country
10.4.1 Middle East & Africa Computational Immunology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Computational Immunology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 EpiVax
11.1.1 EpiVax Company Details
11.1.2 EpiVax Business Overview
11.1.3 EpiVax Computational Immunology Introduction
11.1.4 EpiVax Revenue in Computational Immunology Business (2016-2021)
11.1.5 EpiVax Recent Development
11.2 Novozymes Biopharma
11.2.1 Novozymes Biopharma Company Details
11.2.2 Novozymes Biopharma Business Overview
11.2.3 Novozymes Biopharma Computational Immunology Introduction
11.2.4 Novozymes Biopharma Revenue in Computational Immunology Business (2016-2021)
11.2.5 Novozymes Biopharma Recent Development
11.3 ioGenetics
11.3.1 ioGenetics Company Details
11.3.2 ioGenetics Business Overview
11.3.3 ioGenetics Computational Immunology Introduction
11.3.4 ioGenetics Revenue in Computational Immunology Business (2016-2021)
11.3.5 ioGenetics Recent Development
11.4 International Society of Vaccines
11.4.1 International Society of Vaccines Company Details
11.4.2 International Society of Vaccines Business Overview
11.4.3 International Society of Vaccines Computational Immunology Introduction
11.4.4 International Society of Vaccines Revenue in Computational Immunology Business (2016-2021)
11.4.5 International Society of Vaccines Recent Development
11.5 IMGT
11.5.1 IMGT Company Details
11.5.2 IMGT Business Overview
11.5.3 IMGT Computational Immunology Introduction
11.5.4 IMGT Revenue in Computational Immunology Business (2016-2021)
11.5.5 IMGT Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Details
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computational Immunology Introduction
11.6.4 Dassault Systemes Revenue in Computational Immunology Business (2016-2021)
11.6.5 Dassault Systemes Recent Development
11.7 Certara
11.7.1 Certara Company Details
11.7.2 Certara Business Overview
11.7.3 Certara Computational Immunology Introduction
11.7.4 Certara Revenue in Computational Immunology Business (2016-2021)
11.7.5 Certara Recent Development
11.8 Chemical Computing Group
11.8.1 Chemical Computing Group Company Details
11.8.2 Chemical Computing Group Business Overview
11.8.3 Chemical Computing Group Computational Immunology Introduction
11.8.4 Chemical Computing Group Revenue in Computational Immunology Business (2016-2021)
11.8.5 Chemical Computing Group Recent Development
11.9 Compugen
11.9.1 Compugen Company Details
11.9.2 Compugen Business Overview
11.9.3 Compugen Computational Immunology Introduction
11.9.4 Compugen Revenue in Computational Immunology Business (2016-2021)
11.9.5 Compugen Recent Development
11.10 Genedata AG
11.10.1 Genedata AG Company Details
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG Computational Immunology Introduction
11.10.4 Genedata AG Revenue in Computational Immunology Business (2016-2021)
11.10.5 Genedata AG Recent Development
11.11 Insilico Biotechnology AG
11.11.1 Insilico Biotechnology AG Company Details
11.11.2 Insilico Biotechnology AG Business Overview
11.11.3 Insilico Biotechnology AG Computational Immunology Introduction
11.11.4 Insilico Biotechnology AG Revenue in Computational Immunology Business (2016-2021)
11.11.5 Insilico Biotechnology AG Recent Development
11.12 Leadscope Inc
11.12.1 Leadscope Inc Company Details
11.12.2 Leadscope Inc Business Overview
11.12.3 Leadscope Inc Computational Immunology Introduction
11.12.4 Leadscope Inc Revenue in Computational Immunology Business (2016-2021)
11.12.5 Leadscope Inc Recent Development
11.13 Nimbus Discovery
11.13.1 Nimbus Discovery Company Details
11.13.2 Nimbus Discovery Business Overview
11.13.3 Nimbus Discovery Computational Immunology Introduction
11.13.4 Nimbus Discovery Revenue in Computational Immunology Business (2016-2021)
11.13.5 Nimbus Discovery Recent Development
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Details
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Computational Immunology Introduction
11.14.4 Strand Life Sciences Revenue in Computational Immunology Business (2016-2021)
11.14.5 Strand Life Sciences Recent Development
11.15 Schrodinger
11.15.1 Schrodinger Company Details
11.15.2 Schrodinger Business Overview
11.15.3 Schrodinger Computational Immunology Introduction
11.15.4 Schrodinger Revenue in Computational Immunology Business (2016-2021)
11.15.5 Schrodinger Recent Development
11.16 Simulation Plus
11.16.1 Simulation Plus Company Details
11.16.2 Simulation Plus Business Overview
11.16.3 Simulation Plus Computational Immunology Introduction
11.16.4 Simulation Plus Revenue in Computational Immunology Business (2016-2021)
11.16.5 Simulation Plus Recent Development
11.17 Rosa & Co
11.17.1 Rosa & Co Company Details
11.17.2 Rosa & Co Business Overview
11.17.3 Rosa & Co Computational Immunology Introduction
11.17.4 Rosa & Co Revenue in Computational Immunology Business (2016-2021)
11.17.5 Rosa & Co Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Computational Immunology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cancer Diagnosis & Therapy
Table 3. Key Players of Reverse Vaccinology
Table 4. Key Players of Immune System Modeling
Table 5. Global Computational Immunology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Computational Immunology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Computational Immunology Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Computational Immunology Market Share by Regions (2016-2021)
Table 9. Global Computational Immunology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Computational Immunology Market Share by Regions (2022-2027)
Table 11. Computational Immunology Market Trends
Table 12. Computational Immunology Market Drivers
Table 13. Computational Immunology Market Challenges
Table 14. Computational Immunology Market Restraints
Table 15. Global Computational Immunology Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Computational Immunology Market Share by Players (2016-2021)
Table 17. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Computational Immunology as of 2020)
Table 18. Ranking of Global Top Computational Immunology Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Computational Immunology Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Computational Immunology Product Solution and Service
Table 22. Date of Enter into Computational Immunology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Computational Immunology Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Computational Immunology Revenue Market Share by Type (2016-2021)
Table 26. Global Computational Immunology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Computational Immunology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Computational Immunology Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Computational Immunology Revenue Market Share by Application (2016-2021)
Table 30. Global Computational Immunology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Computational Immunology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Computational Immunology Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Computational Immunology Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Computational Immunology Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Computational Immunology Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Computational Immunology Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Computational Immunology Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Computational Immunology Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Computational Immunology Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Computational Immunology Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Computational Immunology Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Computational Immunology Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Computational Immunology Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Computational Immunology Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Computational Immunology Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Computational Immunology Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Computational Immunology Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Computational Immunology Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Computational Immunology Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Computational Immunology Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Computational Immunology Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Computational Immunology Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Computational Immunology Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Computational Immunology Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Computational Immunology Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Computational Immunology Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Computational Immunology Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Computational Immunology Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Computational Immunology Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Computational Immunology Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Computational Immunology Market Size by Country (2022-2027) & (US$ Million)
Table 62. EpiVax Company Details
Table 63. EpiVax Business Overview
Table 64. EpiVax Computational Immunology Product
Table 65. EpiVax Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 66. EpiVax Recent Development
Table 67. Novozymes Biopharma Company Details
Table 68. Novozymes Biopharma Business Overview
Table 69. Novozymes Biopharma Computational Immunology Product
Table 70. Novozymes Biopharma Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 71. Novozymes Biopharma Recent Development
Table 72. ioGenetics Company Details
Table 73. ioGenetics Business Overview
Table 74. ioGenetics Computational Immunology Product
Table 75. ioGenetics Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 76. ioGenetics Recent Development
Table 77. International Society of Vaccines Company Details
Table 78. International Society of Vaccines Business Overview
Table 79. International Society of Vaccines Computational Immunology Product
Table 80. International Society of Vaccines Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 81. International Society of Vaccines Recent Development
Table 82. IMGT Company Details
Table 83. IMGT Business Overview
Table 84. IMGT Computational Immunology Product
Table 85. IMGT Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 86. IMGT Recent Development
Table 87. Dassault Systemes Company Details
Table 88. Dassault Systemes Business Overview
Table 89. Dassault Systemes Computational Immunology Product
Table 90. Dassault Systemes Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 91. Dassault Systemes Recent Development
Table 92. Certara Company Details
Table 93. Certara Business Overview
Table 94. Certara Computational Immunology Product
Table 95. Certara Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 96. Certara Recent Development
Table 97. Chemical Computing Group Company Details
Table 98. Chemical Computing Group Business Overview
Table 99. Chemical Computing Group Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 100. Chemical Computing Group Recent Development
Table 101. Compugen Company Details
Table 102. Compugen Business Overview
Table 103. Compugen Computational Immunology Product
Table 104. Compugen Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 105. Compugen Recent Development
Table 106. Genedata AG Company Details
Table 107. Genedata AG Business Overview
Table 108. Genedata AG Computational Immunology Product
Table 109. Genedata AG Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 110. Genedata AG Recent Development
Table 111. Insilico Biotechnology AG Company Details
Table 112. Insilico Biotechnology AG Business Overview
Table 113. Insilico Biotechnology AG Computational Immunology Product
Table 114. Insilico Biotechnology AG Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 115. Insilico Biotechnology AG Recent Development
Table 116. Leadscope Inc Company Details
Table 117. Leadscope Inc Business Overview
Table 118. Leadscope Inc Computational Immunology Product
Table 119. Leadscope Inc Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 120. Leadscope Inc Recent Development
Table 121. Nimbus Discovery Company Details
Table 122. Nimbus Discovery Business Overview
Table 123. Nimbus Discovery Computational Immunology Product
Table 124. Nimbus Discovery Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 125. Nimbus Discovery Recent Development
Table 126. Strand Life Sciences Company Details
Table 127. Strand Life Sciences Business Overview
Table 128. Strand Life Sciences Computational Immunology Product
Table 129. Strand Life Sciences Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 130. Strand Life Sciences Recent Development
Table 131. Schrodinger Company Details
Table 132. Schrodinger Business Overview
Table 133. Schrodinger Computational Immunology Product
Table 134. Schrodinger Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 135. Schrodinger Recent Development
Table 136. Simulation Plus Company Details
Table 137. Simulation Plus Business Overview
Table 138. Simulation Plus Computational Immunology Product
Table 139. Simulation Plus Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 140. Simulation Plus Recent Development
Table 141. Rosa & Co Company Details
Table 142. Rosa & Co Business Overview
Table 143. Rosa & Co Computational Immunology Product
Table 144. Rosa & Co Revenue in Computational Immunology Business (2016-2021) & (US$ Million)
Table 145. Rosa & Co Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Computational Immunology Market Share by Type: 2020 VS 2027
Figure 2. Cancer Diagnosis & Therapy Features
Figure 3. Reverse Vaccinology Features
Figure 4. Immune System Modeling Features
Figure 5. Global Computational Immunology Market Share by Application: 2020 VS 2027
Figure 6. Allergy Prediction Databases Case Studies
Figure 7. Analysis Resource Database Case Studies
Figure 8. International Immunogenetics System Case Studies
Figure 9. The Ontology Of Immune Epitopes Case Studies
Figure 10. Immune Epitope Database Case Studies
Figure 11. Computational Immunology Report Years Considered
Figure 12. Global Computational Immunology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Computational Immunology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Computational Immunology Market Share by Regions: 2020 VS 2027
Figure 15. Global Computational Immunology Market Share by Regions (2022-2027)
Figure 16. Global Computational Immunology Market Share by Players in 2020
Figure 17. Global Top Computational Immunology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Computational Immunology as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Computational Immunology Revenue in 2020
Figure 19. Global Computational Immunology Revenue Market Share by Type (2016-2021)
Figure 20. Global Computational Immunology Revenue Market Share by Type (2022-2027)
Figure 21. North America Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Computational Immunology Market Share by Type (2016-2027)
Figure 23. North America Computational Immunology Market Share by Application (2016-2027)
Figure 24. North America Computational Immunology Market Share by Country (2016-2027)
Figure 25. United States Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Computational Immunology Market Share by Type (2016-2027)
Figure 29. Europe Computational Immunology Market Share by Application (2016-2027)
Figure 30. Europe Computational Immunology Market Share by Country (2016-2027)
Figure 31. Germany Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Computational Immunology Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Computational Immunology Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Computational Immunology Market Share by Region (2016-2027)
Figure 41. China Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Computational Immunology Market Share by Type (2016-2027)
Figure 49. Latin America Computational Immunology Market Share by Application (2016-2027)
Figure 50. Latin America Computational Immunology Market Share by Country (2016-2027)
Figure 51. Mexico Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Computational Immunology Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Computational Immunology Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Computational Immunology Market Share by Country (2016-2027)
Figure 57. Turkey Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Computational Immunology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. EpiVax Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 61. Novozymes Biopharma Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 62. ioGenetics Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 63. International Society of Vaccines Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 64. IMGT Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 65. Dassault Systemes Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 66. Certara Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 67. Chemical Computing Group Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 68. Compugen Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 69. Genedata AG Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 70. Insilico Biotechnology AG Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 71. Leadscope Inc Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 72. Nimbus Discovery Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 73. Strand Life Sciences Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 74. Schrodinger Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 75. Simulation Plus Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 76. Rosa & Co Revenue Growth Rate in Computational Immunology Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed